Who invested in Neon Therapeutics?
Neon Therapeutics's investors include Access Industries, Fidelity, Wellington Management, Hill House Capital and Casdin Capital, and 7 more on record.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$161Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $106M sold, first sale Dec 2016
Reported by FinSMEsSEC filing: $70M sold, first sale Dec 2016
From a historical funding record
From the SEC filings it signed: 4 on the team.
On the board, as filediCary PfefferEric LanderRobert KamenRobert TepperStephen Sherwin
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Neon Therapeutics's investors include Access Industries, Fidelity, Wellington Management, Hill House Capital and Casdin Capital, and 7 more on record.
Neon Therapeutics has raised $161M across 3 rounds since 2015.
Neon Therapeutics's most recent round was a Series B of $36M in Dec 2017.
Neon Therapeutics's largest round on record is $70M (Series B), in Jan 2017.
Neon Therapeutics's first round on record, in Oct 2015, was backed by Third Rock Ventures, Access Industries and Clal Biotechnology.
Neon Therapeutics's latest named round is a Series B, in Dec 2017.
Neon Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.